![](/img/cover-not-exists.png)
232 HYBRID MINIMALLY INVASIVE ESOPHAGECTOMY FOR ESOPHAGEAL CANCER: FIVE-YEAR SURVIVAL RESULTS OF THE MIRO TRIAL.
Nuytens, F, Dabakuyo-Yonli, S, Meunier, B, Pezet, D, Collet, D, DJourno, X, Brigand, C, Perniceni, T, Carrère, N, Mabrut, J, Msika, S, Peschaud, F, Prudhomme, M, Mariette, C, Markar, S, Piessen, GVolume:
33
Journal:
Diseases of the Esophagus
DOI:
10.1093/dote/doaa087.41
Date:
September, 2020
File:
PDF, 183 KB
2020